NOVEL COMPOUND AND PHARMACEUTICALLY-ACCEPTABLE SALT THEREOF

Provided is a compound represented by general formula (1) or a pharmaceutically-acceptable salt thereof. In formula (1), R1 and R2 may be the same or different from each other, and each represents a hydrogen atom, a halogen atom, a hydroxy group, a carboxy group, a cyano group, or an optionally-subs...

Full description

Saved in:
Bibliographic Details
Main Authors YAMAKAWA TAKERU, ISSHIKI SATOSHI, TABATA YUJI, MATSUHIRA TAKASHI, OUCHI SHOHEI, WAKIYAMA YOSHINARI, ISHIDA NATSUKI, TAMURA KEIJI
Format Patent
LanguageChinese
English
Published 09.08.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Provided is a compound represented by general formula (1) or a pharmaceutically-acceptable salt thereof. In formula (1), R1 and R2 may be the same or different from each other, and each represents a hydrogen atom, a halogen atom, a hydroxy group, a carboxy group, a cyano group, or an optionally-substituted C1-6 alkyl group or the like; R3 represents a hydrogen atom; R4 represents an optionally-substituted 4- to 10-membered monocyclic heterocyclic group containing 1-4 heteroatoms selected from an oxygen atom, a nitrogen atom, and a sulfur atom; X represents a group represented by -CH2-, -CH2-CH2-, -CH2-CH2-CH2-, or -CH2-O-CH2-; and Z represents a hydrogen atom or a hydroxy group. 本发明涉及一种下述通式(1)所表示的化合物或其药理学上所容许的盐。[式(1)中,R及R可以相同也可以不同,各自表示氢原子、卤原子、羟基、羧基、氰基、可经取代的C烷基等;R表示氢原子;R表示可经取代的包含选自氧原子、氮原子及硫原子中1~4个杂原子的4~10元的单环式杂环基;X表示下述式:-CH-、-CH-CH-、-CH-CH-CH-、或-CH-O-CH-所表示的基;Z表示氢原子或羟基]。
Bibliography:Application Number: CN201780080389